ProShares UltraShort NASDAQ Biotechnology
13 hedge funds and large institutions have $5.17M invested in ProShares UltraShort NASDAQ Biotechnology in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 5 closing their positions.
Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
–
Closed
5
Calls
$2.87M
Puts
–
Net Calls
+$2.87M
Net Calls Change
+$1.9M
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$1.57M |
| 2 |
VF
2
Virtu Financial
New York
|
$784K |
| 3 |
HF
3
HRT Financial
New York
|
$411K |
| 4 |
4
Jane Street
New York
|
$334K |
| 5 |
FAM
5
Fred Alger Management
New York
|
$245K |
